Respiratory Disease Research
The respiratory system consists of the lungs, airways, diaphragm, trachea (windpipe) and pharynx (throat) and its primary function is the exchange of oxygen and carbon dioxide- breathing in and out. Between 6 and 10 liters of air are brought in and out of the lungs and 0.3 liters of oxygen are transferred from the alveoli to the blood per minute.
Respiratory Disease Research Products Areas
Products for Respiratory Disease Research - Page 14
- Cat.No. Product Name Information/Activity
-
BCC7598
PSB 603
1092351-10-4
-
BCC6313
Eact
Eact is a selective and potent activator of TMEM16A, directly activates the TRPV1 channels in sensory nociceptors and produces itch, acute nociception and thermal hypersensitivity.
-
BCC4634
Benzbromarone
Benzbromarone is a highly effective and well tolerated non-competitive inhibitor of xanthine oxidase, used as an uricosuric agent, used in the treatment of gout.
-
BCC6314
CaCCinh-A01
CaCCinh-A01 is an inhibitor of both TMEM16A and calcium-activated chloride channel (CaCC) with IC50s of 2.1 and 10 μM, respectively.
-
BCC4419
CFTRinh-172
CFTR(inh)-172 is a potent and selective blocker of the CFTR chloride channel; reversibly inhibits CFTR short-circuit current in less than 2 minutes with a Ki of 300 nM.
-
BCC7055
Chromanol 293B
163163-23-3
-
BCC7105
DCPIB
DCPIB is a selective, reversible and potent inhibitor of volume-regulated anion channels (VRAC), voltage-dependently activates potassium channels TREK1 and TRAAK, inhibits TRESK, TASK1 and TASK3 (IC50s, 0.14, 0.95, 50.72 μM, respectively). DCPIB is also a selective blocker of swelling-induced chloride current (ICl,swell), with an IC50 of 4.1 μM in CPAE cells.
-
BCC7942
DIDS
Chloride channel blocker; TRPV1 modulator; RAD51 recombinase inhibitor
-
BCC6326
GaTx2
194665-85-5
-
BCC4784
Glyburide
Glibenclamide is a selective inhibitor of ATP-sensitive K+ channel.
